Novel Treatments to Enhance Smoking Cessation before Cancer Surgery: Effects on Smoking and Surgical Outcomes
What is the purpose of this trial?
Phase II: The primary aim of the study is to develop an effect size estimate for smoking cessation with contingency management for biochemically confirmed 7-day point prevalence abstinence during the last week of treatment prior to surgery.
Phase III: To examine changes in serum bilirubin and skin carotenoids after smoking cessation
- 18 Years and older
- National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
- May 2011
- Last Updated:
- Study HIC#: